» Articles » PMID: 25939783

Plumbagin Protects Against Glucocorticoid-induced Osteoporosis Through Nrf-2 Pathway

Overview
Publisher Elsevier
Specialty Cell Biology
Date 2015 May 6
PMID 25939783
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Long-term and high-dose glucocorticoids (GCs) supplementation has been linked to osteoporosis. In this study, we studied the protective role of plumbagin against GC-induced cell damage in MC3T3-E1 cells. The effect of dexamethasone (DEX) and plumbagin on cell viability was determined. DEX showed as IC-50 value of 95 μM. Further, 10 μM plumbagin treatment effectively ameliorated DEX-induced cell death by increasing the cell viability to 92 %. A further effect of plumbagin on DEX-induced oxidative stress was determined through reactive oxygen species (ROS) level, lipid peroxide content, and antioxidant status. Nrf-2 nuclear localization was analyzed through immunofluorescence. Protein expression of redox regulator Nrf-2 and their target genes HO-1 and NQO1 and osteogenic markers (OCN, OPN Runx-2) were determined by Western blot. Apoptotic effect was analyzed by mitochondrial membrane potential and caspase activities (3, 8, and 9). The results showed that DEX treatment showed a significant increase in oxidative stress through increased ROS levels and downregulation of cytoprotective antioxidant proteins and antioxidant enzyme activities. Further DEX treatment downregulated the osteogenic markers and upregulated apoptosis through decreased mitochondrial membrane potential and upregulation of caspase activities. Plumbagin treatment significantly reversed the levels of oxidative stress and apoptotic markers and protected against DEX-induced cell damage. Further, plumbagin treatment significantly improved the expression of osteogenic markers compared to DEX treatment. In conclusion, the present study shows that plumbagin offers significant protective role against DEX-induced cellular damage via regulating oxidative stress, apoptosis, and osteogenic markers.

Citing Articles

Plumbagin ameliorates LPS-induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1-Nrf2/HO-1 signalling pathways.

Liu Z, Wei J, Sun H, Xu L J Cell Mol Med. 2024; 28(13):e18386.

PMID: 38990057 PMC: 11238321. DOI: 10.1111/jcmm.18386.


Plumbagin, a Natural Compound with Several Biological Effects and Anti-Inflammatory Properties.

Petrocelli G, Marrazzo P, Bonsi L, Facchin F, Alviano F, Canaider S Life (Basel). 2023; 13(6).

PMID: 37374085 PMC: 10301567. DOI: 10.3390/life13061303.


Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview.

Wang L, Chen L, Chen K Int J Mol Sci. 2023; 24(6).

PMID: 36982891 PMC: 10054048. DOI: 10.3390/ijms24065814.


Drug Value of Drynariae Rhizoma Root-Derived Extracellular Vesicles for Neurodegenerative Diseases Based on Proteomics and Bioinformatics.

Cao Y, Zhao Q, Liu F, Zheng L, Lin X, Pan M Plant Signal Behav. 2022; 17(1):2129290.

PMID: 36196516 PMC: 9542947. DOI: 10.1080/15592324.2022.2129290.


Tocotrienol as a Protecting Agent against Glucocorticoid-Induced Osteoporosis: A Mini Review of Potential Mechanisms.

Ekeuku S, Ramli E, Abdullah Sani N, Ghafar N, Soelaiman I, Chin K Molecules. 2022; 27(18).

PMID: 36144598 PMC: 9506150. DOI: 10.3390/molecules27185862.


References
1.
Feng Y, Tang X . Effect of glucocorticoid-induced oxidative stress on the expression of Cbfa1. Chem Biol Interact. 2013; 207:26-31. DOI: 10.1016/j.cbi.2013.11.004. View

2.
Canalis E . Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology. 1983; 112(3):931-9. DOI: 10.1210/endo-112-3-931. View

3.
Sosa M, Jodar E, Saavedra P, Navarro M, Gomez de Tejada M, Martin A . Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant.... Eur J Intern Med. 2008; 19(1):51-6. DOI: 10.1016/j.ejim.2007.08.005. View

4.
Sugie S, Okamoto K, Rahman K, Tanaka T, Kawai K, Yamahara J . Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett. 1998; 127(1-2):177-83. DOI: 10.1016/s0304-3835(98)00035-4. View

5.
Mazziotti G, Angeli A, Bilezikian J, Canalis E, Giustina A . Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab. 2006; 17(4):144-9. DOI: 10.1016/j.tem.2006.03.009. View